ResearcherUniversity of California, BerkeleyNo recent work listed

Daniel K. Nomura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1614-8360; OpenAlex author ID A5035184259. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper

Papers 1

Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. Last author DOI 10.1021/acschembio.7b00020 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Allison M. Roberts · 1 shared paper, 2017 · strength 0.06
- Paper Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. DOI 10.1021/acschembio.7b00020 ↗
Martin J. Heslin · 1 shared paper, 2017 · strength 0.06
- Paper Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. DOI 10.1021/acschembio.7b00020 ↗
Carlo M. Contreras · 1 shared paper, 2017 · strength 0.06
- Paper Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. DOI 10.1021/acschembio.7b00020 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.